IL10 and cancer: The underlying mechanism primarily involves the systemic inflammatory response from cancer cells promoting neutrophil infiltration, which subsequently promotes cancer progression through the secretion of interleukin-2 (IL-2), IL-6, IL-10, tumour necrosis factor-α and vascular endothelial growth factor.